Spandidos Publications style
Sedliarou I, Saenko V, Lantsov D, Rogounovitch T, Namba H, Abrosimov A, Lushnikov E, Kumagai A, Nakashima M, Meirmanov S, Meirmanov S, et al: The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. Int J Oncol 25: 1729-1735, 2004.
APA
Sedliarou, I., Saenko, V., Lantsov, D., Rogounovitch, T., Namba, H., Abrosimov, A. ... Yamashita, S. (2004). The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. International Journal of Oncology, 25, 1729-1735. https://doi.org/10.3892/ijo.25.6.1729
MLA
Sedliarou, I., Saenko, V., Lantsov, D., Rogounovitch, T., Namba, H., Abrosimov, A., Lushnikov, E., Kumagai, A., Nakashima, M., Meirmanov, S., Mine, M., Hayashi, T., Yamashita, S."The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma". International Journal of Oncology 25.6 (2004): 1729-1735.
Chicago
Sedliarou, I., Saenko, V., Lantsov, D., Rogounovitch, T., Namba, H., Abrosimov, A., Lushnikov, E., Kumagai, A., Nakashima, M., Meirmanov, S., Mine, M., Hayashi, T., Yamashita, S."The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma". International Journal of Oncology 25, no. 6 (2004): 1729-1735. https://doi.org/10.3892/ijo.25.6.1729
